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Dispersed nanostructured liquid crystalline materials are promising candidates for drug delivery and 
other pharmaceutical applications1. They can be easily formed from nanoprecipitation or solvent 
shifting methods with amphiphiles, however the mechanism of their formation and their stability with 
time are still under debate.2  
A particular case of such nanostructures was introduced in 2006 by Couvreur et al.3 They take 
benefit of the amphiphilic properties of conjugates formed by the covalent link between a squalene 
moity and a drug (or a nucleosides) to form such dispersions. The high loading capacity of these 
nanoparticles and their specific structure induces a large improvement of their therapeutic efficacy in 
comparison to the single drug. To improve the use of these nanoparticles in drug delivery, a deeper 
understanding of the mechanism of formation could provide the keys for a better control over size 
distribution and stability. After a short summary on nanoprecipitation and solvent shifting methods, 
this presentation will focuses on the Squalenoyl based nanoparticles formation. Size and structural 
analysis by Small Angle Neutron Scattering revealed the paramount role of the solvent on the control 
of size3 and the effect of the formulation parameters.4  
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SANS patterns of the intermediate state of deoxycytidine squalene 
(SqDc) nanoparticles dispersion obtained with drop by drop 
nanoprecipitation (addition of SqDc/ ethanol–H solution into D2O). 
top inset : zoom on the Bragg peaks, down inset : Molecular 
structure of deoxycytidine squalene.  
